Gross; Steven S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gross; Steven S..The latest application filed is for "pharmacotherapy for vascular dysfuntion associated with deficient nitric oxide bioactivity".

Company Profile

0.14.2

Gross; Steven S. - New York NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Reversing or preventing premature vascular senescence Grant 6,967,219 - Gross , et al. November 22, 2	2005-11-22
Pharmacotherapy for vascular dysfunction associated with deficient nitric oxide bioactivity Grant 6,784,178 - Gross , et al. August 31, 2	2004-08-31
Pharmacotherapy for vascular dysfuntion associated with deficient nitric oxide bioactivity App 20030212135 - Gross, Steven S. ; et al.	2003-11-13
Reversing or preventing premature vascular senescence App 20030073747 - Gross, Steven S. ; et al.	2003-04-17
Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis Grant 6,274,581 - Gross August 14, 2	2001-08-14
Treatments based on discovery that nitric oxide synthase is a paraquat diaphorase Grant 6,231,894 - Stamler , et al. May 15, 2	2001-05-15
Blocking induction of tetrahydrobioterin to block induction of nitric oxide synthesis Grant 6,153,615 - Gross November 28, 2	2000-11-28
Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis Grant 5,880,124 - Gross March 9, 1	1999-03-09
Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis Grant 5,877,176 - Gross March 2, 1	1999-03-02
Preventing conversion of citrulline to argininosuccinate to limit pathological nitric oxide overproduction Grant 5,723,448 - Gross , et al. March 3, 1	1998-03-03
Preventing conversion of citrulline to argininosuccinate to limit pathological nitric oxide overproduction Grant 5,545,625 - Gross , et al. August 13, 1	1996-08-13
Blocking utilization of tetrahydrobiopterin to block induction of nitric oxide synthesis Grant 5,502,050 - Gross March 26, 1	1996-03-26
Method for treating systemic hypotension caused by sepsis or cytokine using arginase in combination with an .alpha..sub.1 adrenergic agonist Grant 5,395,612 - Griffith , et al. March 7, 1	1995-03-07
Use of cardiotonic drugs and inhibitors of nitric oxide synthesis to alleviate pathologic hypotension Grant 5,312,835 - Kilbourn , et al. * May 17, 1	1994-05-17
Parenteral formulations for the inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor Grant 5,286,739 - Kilbourn , et al. February 15, 1	1994-02-15
Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients Grant 5,216,025 - Gross , et al. June 1, 1	1993-06-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.